This site is intended for healthcare professionals

Magnifying glass on blue background; searching for results

Find disease awareness content and relevant supporting materials

Learning Zone 477 Events 9 News 20027 Drugs 42604 Trials 863 Guidelines 631 Journals 1966

Blue test tubes arranged in a line, disappearing into the background

New European data presented from PROVE study, the largest real-world evidence study of Fetroja/Fetcroja (cefiderocol) for serious Gram-negative (GN) bacterial infections.- Shionogi

1 min read

Blue test tubes arranged in a line, disappearing into the background

First patient enrolled in FORWARD CAD pivotal study of novel forward intravascular lithotripsy platform - Shockwave Medical/Johnson & Johnson MedTech

2 min read

Blue test tubes arranged in a line, disappearing into the background

FDA approves Opdivo (nivolumab) plus Yervoy (ipilimumab) as a treatment for patients with previously untreated microsatellite instability-high or mismatch repair deficient unresectable or metastatic colorectal cancer - BMS

5 min read

Blue test tubes arranged in a line, disappearing into the background

The effect of aprocitentan for reducing blood pressure and proteinuria in black patients with resistant hypertension published in Hypertension- Idorsia

1 min read

Blue test tubes arranged in a line, disappearing into the background

FDA approves an updated label for Tryvio (aprocitentan) removing the REMS requirement- Idorsia

1 min read

Blue test tubes arranged in a line, disappearing into the background

Bayer files for approval of aflibercept 8 mg for treatment of retinal vein occlusion in EU

1 min read

Blue test tubes arranged in a line, disappearing into the background

Tremfya (guselkumab) is the first and only IL-23 inhibitor to significantly reduce both the signs, symptoms and progression of structural damage in adults living with active psoriatic arthritis - Johnson & Johnson

1 min read

Blue test tubes arranged in a line, disappearing into the background

Pacira BioSciences announces first patient dosed in phase II study evaluating safety and efficacy of PCRX 201 (enekinragene inzadenovec) for the treatment of osteoarthritis of the knee

2 min read

Blue test tubes arranged in a line, disappearing into the background

Rilzabrutinib granted orphan drug designation in the US for warm autoimmune hemolytic anemia and IgG4-related disease , two rare diseases- Sanofi

1 min read

Blue test tubes arranged in a line, disappearing into the background

NICE (UK) terminated appraisal for Onivyde (pegylated liposomal irinotecan) in combination for untreated metastatic pancreatic cancer - Servier

1 min read